Chimeric antigen receptor T cells (CAR-Ts) have remarkable efficacy in liquid tumors, but limited responses in solid tumors. We conducted a Phase I trial (NCT02107963) of GD2 CAR-Ts (GD2-CAR.OX40.28.z.iC9), demonstrating feasibility and safety of administration in children and young adults with osteosarcoma and neuroblastoma. Since CAR-T efficacy requires adequate CAR-T expansion, patients were grouped into good or poor expanders across dose levels. Patient samples were evaluated by multi-dimensional proteomic, transcriptomic, and epigenetic analyses. T cell assessments identified naive T cells in pre-treatment apheresis associated with good expansion, and exhausted T cells in CAR-T products with poor expansion. Myeloid cell assessment identified CXCR3+ monocytes in pre-treatment apheresis associated with good expansion. Longitudinal analysis of post-treatment samples identified increased CXCR3- classical monocytes in all groups as CAR-T numbers waned. Together, our data uncover mediators of CAR-T biology and correlates of expansion that could be utilized to advance immunotherapies for solid tumor patients.
Pubmed ID: 38134936 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This monoclonal targets CD16
View all literature mentionsThis monoclonal targets CD279/PD-1
View all literature mentionsThis monoclonal targets EOMES
View all literature mentionsThis unknown targets Hydrocodone
View all literature mentionsThis monoclonal targets CD95
View all literature mentionsThis monoclonal targets CD122
View all literature mentionsThis polyclonal targets polyclonal anti-Clostridium botulinum D Toxoid
View all literature mentionsThis monoclonal targets CD45RA
View all literature mentionsThis monoclonal targets TIM-3
View all literature mentionsThis monoclonal targets CD127/IL-7Ra
View all literature mentionsThis monoclonal targets CD160
View all literature mentionsThis monoclonal targets CD223
View all literature mentionsThis monoclonal targets CD39
View all literature mentionsThis monoclonal targets CD272/BTLA
View all literature mentionsThis monoclonal targets CD25
View all literature mentionsThis monoclonal targets CD152/CTLA-4
View all literature mentionsThis monoclonal targets Tbet
View all literature mentionsThis monoclonal targets CD20
View all literature mentionsThis monoclonal targets CD137/4-1BB
View all literature mentionsThis recombinant monoclonal targets Cleaved PARP
View all literature mentionsThis monoclonal targets TIGIT
View all literature mentionsThis monoclonal targets CD38
View all literature mentionsThis monoclonal targets CD244
View all literature mentionsThis monoclonal targets CD134/OX40
View all literature mentionsThis monoclonal targets CD45RO
View all literature mentionsThis monoclonal targets CD274/PDL1
View all literature mentionsThis monoclonal targets CD28
View all literature mentionsThis monoclonal targets CD8
View all literature mentionsThis unknown targets
View all literature mentionsThis monoclonal targets CD11b
View all literature mentionsThis monoclonal targets CD57
View all literature mentionsThis monoclonal targets CD27
View all literature mentionsThis monoclonal targets CD45
View all literature mentionsThis monoclonal targets CD3
View all literature mentionsThis monoclonal targets CD66b
View all literature mentionsThis cocktail targets CD3, CD19, CD20, CD56
View all literature mentionsThis monoclonal targets Slan (M-DC8)
View all literature mentionsThis monoclonal targets CD3
View all literature mentionsThis monoclonal targets CD183
View all literature mentionsThis monoclonal targets HLA-DR
View all literature mentionsThis monoclonal targets CD16
View all literature mentionsThis monoclonal targets CD15
View all literature mentionsThis monoclonal targets CD33
View all literature mentionsThis monoclonal targets CD14
View all literature mentionsThis monoclonal targets CD11b
View all literature mentionsThis monoclonal targets CD25
View all literature mentionsThis monoclonal targets CD62L (L-Selectin)
View all literature mentionsThis unknown targets Yeast Rpn12
View all literature mentionsThis monoclonal targets CD95
View all literature mentionsThis monoclonal targets CD4
View all literature mentionsThis monoclonal targets CD8
View all literature mentionsThis monoclonal targets CD3
View all literature mentionsThis monoclonal targets CD45
View all literature mentionsThis monoclonal targets CD11b/Mac-1
View all literature mentionsThis monoclonal targets CD56
View all literature mentionsThis monoclonal targets CD10
View all literature mentionsThis monoclonal targets CD169
View all literature mentionsThis monoclonal targets Ki67
View all literature mentionsThis monoclonal targets CD141
View all literature mentionsThis monoclonal targets CD9
View all literature mentionsThis monoclonal targets CD152/CTLA-4
View all literature mentionsThis monoclonal targets Slan (M-DC8)
View all literature mentionsThis monoclonal targets LT-betaR
View all literature mentionsThis monoclonal targets CD197/CCR7
View all literature mentionsThis monoclonal targets CD279
View all literature mentionsThis monoclonal targets CD16
View all literature mentionsThis monoclonal targets CD15/SSEA-1
View all literature mentionsThis monoclonal targets CD33
View all literature mentionsThis monoclonal targets CD273
View all literature mentionsThis monoclonal targets CD253
View all literature mentionsThis monoclonal targets CD14
View all literature mentionsThis monoclonal targets CD357 (GITR)
View all literature mentionsThis monoclonal targets CD183/CXCR3
View all literature mentionsThis unknown targets CD33
View all literature mentionsThis monoclonal targets CD36
View all literature mentionsThis monoclonal targets CD142
View all literature mentionsThis unknown targets CD66b
View all literature mentionsThis monoclonal targets CD103
View all literature mentionsThis monoclonal targets CD206
View all literature mentionsThis monoclonal targets CD45RA
View all literature mentionsThis monoclonal targets CD3
View all literature mentionsThis monoclonal targets CD69
View all literature mentionsThis monoclonal targets CD123
View all literature mentionsThis monoclonal targets CD19
View all literature mentionsThis monoclonal targets CD1c
View all literature mentionsThis monoclonal targets CD235ab
View all literature mentionsThis monoclonal targets CD41
View all literature mentionsThis monoclonal targets CD45
View all literature mentionsThis monoclonal targets HLA-DR
View all literature mentions